Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...

Just one weekly puff from an asthma-like inhaler might one day protect you from the viral infections that make winters miserable – and could even save your life in the event of another pandemic. That ...

In recent years, mRNA technology has come into its own, most prominently in the field of vaccine development. After mRNA’s success in the COVID-19 vaccine, companies are now harnessing the molecule to ...

From COVID-19 to the seasonal flu and RSV, vaccinations for respiratory viruses are typically delivered via intramuscular injection, which generates antibodies in the bloodstream. But the first line ...

Houston Methodist Research Institute is collaborating with the Coalition for Epidemic Preparedness Innovations (CEPI) and leading scientific institutions in the Republic of Korea to develop what could ...